Literature DB >> 11219620

Cerebellar gliomas in infants: specificity, pathology, and outcome.

M Vinchon1, M M Ruchoux, G Soto-Ares, R Nicolas, P Dhellemmes.   

Abstract

Cerebellar gliomas (CGs) in children are generally associated with a favorable outcome; however, data regarding these tumors in very young children are scarce. We report on our experience with CGs in children less than 3 years old at surgery, compared with a second group older than 3 years. From 1991 to 1996, we operated on 7 children with CGs in the first group and 43 in the second. Psychomotor delay and regression were the first symptoms in 3 cases, and 3 had macrocrania. The tumor was totally removed in all cases. One child died intraoperatively of air embolism and subdural bleeding. Three had malignant tumors (grade 3 or 4). There was no operative mortality or malignancy in the second group of patients. With a mean follow-up of 33 months, all survivors in the first group are disease-free, with no or minimal symptoms, and attend normal schools. The clinical, surgical, and pathological features suggest that children under 3 years of age represent a specific subgroup of CGs.

Entities:  

Mesh:

Year:  2001        PMID: 11219620     DOI: 10.1007/s003810000356

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  2 in total

1.  Radiologically typical pilocytic astrocytoma with histopathological signs of atypia.

Authors:  Roshanak Daneshzadeh Tabrizi; Michel Mittelbronn; Gerhard Marquardt; Elke Hattingen
Journal:  Childs Nerv Syst       Date:  2012-06-21       Impact factor: 1.475

2.  Cytogenetic analysis of paediatric astrocytoma using comparative genomic hybridisation and fluorescence in-situ hybridisation.

Authors:  Samantha J Ward; Katherine Karakoula; Kim P Phipps; William Harkness; Richard Hayward; Dominic Thompson; Thomas S Jacques; Brian Harding; John L Darling; David G T Thomas; Tracy J Warr
Journal:  J Neurooncol       Date:  2010-01-06       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.